Kymriah
CAR T Rx Kymriah Gains Expanded Approval for Some Large B-Cell Lymphomas
The FDA has granted tisagenlecleucel (Kymriah, Novartis) its second indication—the treatment of adults with ...
MAY 4, 2018
Hospitals Take Lead Role In Newest Gene Cancer Rx
Two revolutionary new cancer therapies that use genetic engineering to treat ALL and certain types of lymphoma are ...
DECEMBER 2, 2017
FDA Approves Kymriah, First Gene Therapy in U.S.
CAR T-cell therapy approved to treat certain children and young adults with B-cell acute lymphoblastic leukemia.
AUGUST 31, 2017
Load more